These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15175703)

  • 1. Harvesting biotechnology.
    Dennis C; Byrne N
    Nature; 2004 Jun; 429(6991 Suppl):1. PubMed ID: 15175703
    [No Abstract]   [Full Text] [Related]  

  • 2. Australian states compete for biotech primacy.
    Norrie C
    Nat Biotechnol; 2002 Aug; 20(8):760. PubMed ID: 12147988
    [No Abstract]   [Full Text] [Related]  

  • 3. Universities could gain from backing biotech.
    Kamb A
    Nature; 2003 Mar; 422(6928):113. PubMed ID: 12634753
    [No Abstract]   [Full Text] [Related]  

  • 4. Norway looks to biotech as the oil starts to run out.
    Hayhurst R
    Drug Discov Today; 2005 Mar; 10(6):387-90. PubMed ID: 15808817
    [No Abstract]   [Full Text] [Related]  

  • 5. Biotech business Down Under.
    Beckley C
    Nature; 2004 Jun; 429(6991 Suppl):5-9. PubMed ID: 15175704
    [No Abstract]   [Full Text] [Related]  

  • 6. A testing approach based on tiny doses still awaits big results.
    Coombs A
    Nat Med; 2008 Aug; 14(8):796. PubMed ID: 18685584
    [No Abstract]   [Full Text] [Related]  

  • 7. The 20-year African biotech plan.
    Singh JA; Daar AS
    Nat Biotechnol; 2008 Mar; 26(3):272-4. PubMed ID: 18327231
    [No Abstract]   [Full Text] [Related]  

  • 8. Fragmentation is industry obstacle in Europe.
    Mitchell P
    Nat Biotechnol; 2001 Jun; 19(6):494-5. PubMed ID: 11385414
    [No Abstract]   [Full Text] [Related]  

  • 9. Australian biotech suffers growing pains.
    O'Neill G
    Nat Biotechnol; 2005 Apr; 23(4):401-2. PubMed ID: 15815652
    [No Abstract]   [Full Text] [Related]  

  • 10. Biodiscovery--from reef to outback.
    Blake D
    Nature; 2004 Jun; 429(6991 Suppl):15-7. PubMed ID: 15175706
    [No Abstract]   [Full Text] [Related]  

  • 11. No longer the upstart.
    Nature; 2005 Jun; 435(7044):879. PubMed ID: 15959487
    [No Abstract]   [Full Text] [Related]  

  • 12. Concern mounts over Munich's BioRegio money.
    Fürst I
    Nat Biotechnol; 1998 Jul; 16(7):614-5. PubMed ID: 9661185
    [No Abstract]   [Full Text] [Related]  

  • 13. Maximizing state and federal spending while minimizing conflicts.
    Billingsley ML; Washko M
    Nat Biotechnol; 2006 Dec; 24(12):1473-4. PubMed ID: 17160036
    [No Abstract]   [Full Text] [Related]  

  • 14. Ireland embraces biotechnology.
    Canning S
    Nat Biotechnol; 2000 Mar; 18(3):273-5. PubMed ID: 10700138
    [No Abstract]   [Full Text] [Related]  

  • 15. Australia. Stem cell center looks to recast itself in supporting role.
    Finkel E
    Science; 2009 Mar; 323(5921):1552-3. PubMed ID: 19299596
    [No Abstract]   [Full Text] [Related]  

  • 16. Portugal opens its borders to biotechnology.
    Louët S
    Nat Biotechnol; 2000 Mar; 18(3):276-7. PubMed ID: 10700139
    [No Abstract]   [Full Text] [Related]  

  • 17. Biotechnology and sustainability: the role of transatlantic cooperation in research and innovation.
    Aguilar A; Bochereau L; Matthiessen-Guyader L
    Trends Biotechnol; 2008 Apr; 26(4):163-5. PubMed ID: 18295918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP under attack.
    Surendran A
    Nat Biotechnol; 2004 Apr; 22(4):477-8. PubMed ID: 15085806
    [No Abstract]   [Full Text] [Related]  

  • 19. Share slump brings biotech firms to government's door.
    Check E
    Nature; 2003 Jun; 423(6943):908. PubMed ID: 12827159
    [No Abstract]   [Full Text] [Related]  

  • 20. A piece of history.
    Nat Biotechnol; 2003 Aug; 21(8):831. PubMed ID: 12894179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.